Michigan K.I.D.S. is the Detroit Newspapers in Education (DNIE) non-profit for the Detroit Free Press and The Detroit News that provides digital e-Editions of the Free Press and The News, related online and print teaching resources, and other services to schools across Michigan.
We need your help!
We rely on the generosity of readers, businesses and foundations to help us provide newspapers and other educational materials and programs to Michigan students.
Common Core State Standard L.CCS.1/2/3/4 Grades 6-12: Video of a current news event is presented for discussion to encourage student participation, but also inspire the use of evidence to support logical claims using the main ideas of the video. Students must analyze background information provided about a current event, draw out the main ideas and key details, and review different opinions on the issue. Then, students should present their own claims using facts and analysis for support.
News Video for: 11/23/2015
Bacteria evolves to defeat 'last resort' antibiotic
Scientists in China have found a resistance gene for colistin, what's commonly known as the "last resort" antibiotic. Colistin has been the drug doctors turned to when all other antibiotics failed to fight life-threatening drug-resistant bacteria. Now, researchers in China have found a new bacteria gene that resists colistan - and it is spreading. Medical researchers fear we are near a post-antibiotic era. "At that point if a patient is seriously ill, say with E. coli, then there is virtually nothing you can do," one doctor said.
Class discussion: The new resistant gene in has been linked to Chinese farmers treating their animals with colistin. How much antibiotics do farmers use on animals? Are their any controls on antibotic use in agriculture? Can antibiotic-resistant bacteria spread to us from the food we eat? How common are outbreaks of food-borne inefections from bacteria like E. coli? Researchers are racing to find new antibiotics. When was the last antibiotic developed? Why has there not been more research on antibiotics by drug firms?